Attached files

file filename
EX-31.2 - SECTION 302 CFO CERTIFICATION - QUAKER CHEMICAL CORPdex312.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - QUAKER CHEMICAL CORPdex321.htm
EX-10.2 - EMPLOYMENT AGREEMENT - QUAKER CHEMICAL CORPdex102.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - QUAKER CHEMICAL CORPdex311.htm
EX-10.3 - CHANGE IN CONTROL AGREEMENT - QUAKER CHEMICAL CORPdex103.htm
EX-10.1 - AMENDED EXPATRIATE AGREEMENT - QUAKER CHEMICAL CORPdex101.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - QUAKER CHEMICAL CORPdex322.htm
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

 

FORM 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2010

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 001-12019

 

 

QUAKER CHEMICAL CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

Pennsylvania   23-0993790

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

One Quaker Park, 901 E. Hector Street,

Conshohocken, Pennsylvania

  19428 – 2380
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: 610-832-4000

Not Applicable

Former name, former address and former fiscal year, if changed since last report.

 

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨  (Do not check if smaller reporting company)    Smaller reporting Company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Number of Shares of Common Stock

Outstanding on March 31, 2010

   11,151,787

 

 

 


Table of Contents

QUAKER CHEMICAL CORPORATION AND CONSOLIDATED SUBSIDIARIES

 

          Page
PART I.    FINANCIAL INFORMATION   
Item 1.    Financial Statements (unaudited)   
   Condensed Consolidated Balance Sheet at March 31, 2010 and December 31, 2009    3
   Condensed Consolidated Statement of Income for the Three Months Ended March 31, 2010 and 2009    4
   Condensed Consolidated Statement of Cash Flows for the Three Months Ended March 31, 2010 and 2009    5
   Notes to Condensed Consolidated Financial Statements    6
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations    17
Item 3.    Quantitative and Qualitative Disclosures about Market Risk    21
Item 4.    Controls and Procedures    22
PART II.    OTHER INFORMATION    23
Item 6.    Exhibits    23
Signatures    23

 

2


Table of Contents

PART I

FINANCIAL INFORMATION

 

Item 1. Financial Statements (Unaudited)

Quaker Chemical Corporation

Condensed Consolidated Balance Sheet

 

     Unaudited
(Dollars in  thousands,
except par value and
share amounts)
 
     March 31,
2010
    December 31,
2009*
 

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 24,820      $ 25,051   

Construction fund (restricted cash)

     407        2,358   

Accounts receivable, net

     110,587        108,793   

Inventories

    

Raw materials and supplies

     27,371        23,495   

Work-in-process and finished goods

     27,087        26,545   

Prepaid expenses and other current assets

     12,929        12,656   
                

Total current assets

     203,201        198,898   
                

Property, plant and equipment, at cost

     187,639        190,980   

Less accumulated depreciation

     (122,078     (123,554
                

Net property, plant and equipment

     65,561        67,426   

Goodwill

     45,509        46,515   

Other intangible assets, net

     5,272        5,579   

Investments in associated companies

     8,836        8,824   

Deferred income taxes

     31,510        31,692   

Other assets

     46,941        39,537   
                

Total assets

   $ 406,830      $ 398,471   
                

LIABILITIES AND EQUITY

    

Current liabilities

    

Short-term borrowings and current portion of long-term debt

   $ 2,485      $ 2,431   

Accounts and other payables

     56,949        60,939   

Accrued compensation

     10,443        16,656   

Accrued pension and postretirement benefits

     4,702        4,717   

Other current liabilities

     16,700        15,224   
                

Total current liabilities

     91,279        99,967   
                

Long-term debt

     71,099        63,685   

Deferred income taxes

     8,613        8,605   

Accrued pension and postretirement benefits

     26,865        27,602   

Other non-current liabilities

     45,859        42,317   
                

Total liabilities

     243,715        242,176   
                

Equity

    

Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding 2010 – 11,151,787; 2009 – 11,085,549 shares

     11,152        11,086   

Capital in excess of par value

     30,277        27,527   

Retained earnings

     129,994        123,140   

Accumulated other comprehensive loss

     (14,058     (10,439
                

Total Quaker shareholders’ equity

     157,365        151,314   
                

Noncontrolling interest

     5,750        4,981   
                

Total equity

     163,115        156,295   
                

Total liabilities and equity

   $ 406,830      $ 398,471   
                

 

* Condensed from audited financial statements

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3


Table of Contents

Quaker Chemical Corporation

Condensed Consolidated Statement of Income

 

     Unaudited
(Dollars in  thousands,
except per
share and share amounts)
Three Months Ended March  31,
 
     2010     2009  

Net sales

   $ 128,320      $ 98,507   

Cost of goods sold

     80,980        69,793   
                

Gross margin

     47,340        28,714   

Selling, general and administrative expenses

     33,669        26,697   

Restructuring and related activities

     —          2,289   
                

Operating income (loss)

     13,671        (272

Other income, net

     763        1,454   

Interest expense

     (1,311     (1,242

Interest income

     184        153   
                

Income before taxes and equity in net loss of associated companies

     13,307        93   

Taxes (tax benefit) on income before equity in net loss of associated companies

     3,181        (251 )
                

Income before equity in net loss of associated companies

     10,126        344   

Equity in net loss of associated companies

     (89     (142
                

Net income

     10,037        202   

Less: Net income attributable to noncontrolling interest

     618        200   
                

Net income attributable to Quaker Chemical Corporation

   $ 9,419      $ 2   
                

Per share data:

    

Net income attributable to Quaker Chemical Corporation Common Shareholders – basic

   $ 0.85      $ 0.00   

Net income attributable to Quaker Chemical Corporation Common Shareholders – diluted

   $ 0.84      $ 0.00   

Dividends declared

   $ 0.23      $ —     

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4


Table of Contents

Quaker Chemical Corporation

Condensed Consolidated Statement of Cash Flows

 

     Unaudited
(Dollars in thousands)
For the Three Months Ended
March 31,
 
     2010     2009  

Cash flows from operating activities

    

Net income

   $ 10,037      $ 202   

Adjustments to reconcile net income to net cash (used in) provided by operating activities:

    

Depreciation

     2,593        2,458   

Amortization

     254        257   

Equity in net loss of associated companies, net of dividends

     89        142   

Deferred compensation and other, net

     289        (2,852

Stock-based compensation

     727        352   

Restructuring and related activities

     —          2,289   

Gain on disposal of property, plant and equipment

     (32     (1,193

Insurance settlement realized

     (345     (144

Pension and other postretirement benefits

     (2,265     (1,907

Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:

    

Accounts receivable

     (3,606     7,196   

Inventories

     (5,332     10,060   

Prepaid expenses and other current assets

     (1,360     34   

Accounts payable and accrued liabilities

     (5,818     (6,045

Change in restructuring liabilities

     —          (2,652
                

Net cash (used in) provided by operating activities

     (4,769     8,197   
                

Cash flows from investing activities

    

Investments in property, plant and equipment

     (2,042     (2,375

Proceeds from disposition of assets

     41        1,605   

Payments related to acquisitions

     —          (1,000

Insurance settlement received and interest earned

     5,038        5,056   

Change in restricted cash, net

     (2,742     (4,086
                

Net cash provided by (used in) investing activities

     295        (800
                

Cash flows from financing activities

    

Net decrease in short-term borrowings

     —          (1,619

Proceeds from long-term debt

     7,583        1,584   

Repayment of long-term debt

     (122     (7,728

Dividends paid

     (2,550     (2,492

Stock options exercised, other

     135        69   

Excess tax benefit related to stock option exercises

     321        —     
                

Net cash provided by (used in) financing activities

     5,367        (10,186
                

Effect of exchange rate changes on cash

     (1,124     (126
                

Net decrease in cash and cash equivalents

     (231     (2,915

Cash and cash equivalents at beginning of period

     25,051        20,892   
                

Cash and cash equivalents at end of period

   $ 24,820      $ 17,977   
                

Supplemental cash flow disclosures:

    

Non-cash activities:

    

Excess tax benefit related to stock option exercises

   $ 1,633      $ —     

Restricted insurance receivable (See also Note 13 of Notes to Condensed Consolidated Financial Statements)

     5,000        5,000   

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements

(Dollars in thousands, except per share amounts)

(Unaudited)

Note 1 – Condensed Financial Information

The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States for interim financial reporting and the United States Securities and Exchange Commission regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. Certain reclassifications of prior years’ data have been made to improve comparability. The results for the three months ended March 31, 2010 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2009.

Effective January 1, 2010, the Venezuelan economy was considered to be hyperinflationary under generally accepted accounting principles in the United States, since it has experienced a rate of general inflation in excess of 100% over the latest three-year period, based upon the blended Consumer Price Index and National Consumer Price Index. Accordingly, all gains and losses resulting from the remeasurement of the Company’s Venezuelan 50% equity affiliate (Kelko Quaker Chemical, S.A.) are required to be recorded directly in the statement of operations. On January 8, 2010, the Venezuelan government announced the devaluation of the Bolivar Fuerte and the establishment of a two-tiered exchange structure. As a result of the devaluation, the Company recorded a charge of approximately $0.03 per diluted share, in the first quarter of 2010.

The Company has been and will recognize certain accelerated and other costs in accordance with the retirement of the Company’s former CEO. The Company expects to incur a final charge of $1,265 later in 2010 related to the former CEO’s supplemental retirement income plan.

As part of the Company’s chemical management services, certain third-party product sales to customers are managed by the Company. Where the Company acts as principal, revenue is recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as agent, such revenue is recorded using net reporting as service revenues, at the amount of the administrative fee earned by the Company for ordering the goods. Third-party products transferred under arrangements resulting in net reporting totaled $12,559 and $4,831 for the three months ended March 31, 2010 and 2009, respectively.

Note 2 – Recently Issued Accounting Standards

The FASB updated its guidance regarding a vendor’s multiple-deliverable arrangements in October 2009. The updated guidance establishes a selling price hierarchy to be followed in determining the selling price for each deliverable in multiple-deliverable arrangements, eliminates the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement using the relative selling price method and requires enhanced disclosure regarding multiple-deliverable arrangements. The guidance is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning after June 15, 2010. The Company is currently assessing the impact of this guidance on its financial statements.

Note 3 – Restructuring and Related Activities

In the first quarter of 2009, Quaker’s management implemented a restructuring program totaling $2,289. The Company completed the initiatives under this program during 2009.

Note 4 – Income Taxes and Uncertain Income Tax Positions

The Company’s low first quarter effective tax rate of 24% reflects the expiration of applicable statutes of limitations for uncertain tax positions of approximately $0.11 per diluted share. The tax benefit recorded in the first quarter of 2009 reflects no tax provided on the gain related to the Company’s disposition of land in Europe due to the utilization of net operating losses not previously benefited.

 

6


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

The FASB’s guidance regarding accounting for uncertainty in income taxes prescribes the recognition threshold and measurement attributes for financial statement recognition and measurement of tax positions taken or expected to be taken on a tax return. The guidance further requires the determination of whether the benefits of tax positions will be more likely than not sustained upon audit based upon the technical merits of the tax position. For tax positions that are determined to be more likely than not sustained upon audit, a company recognizes the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement in the financial statements. For tax positions that are not determined to be more likely than not sustained upon audit, a company does not recognize any portion of the benefit in the financial statements. Additionally, the guidance provides for derecognition, classification, penalties and interest, accounting in interim periods, disclosure and transition.

At December 31, 2009, the Company’s cumulative liability for gross unrecognized tax benefits was $10,686. As of March 31, 2010, the Company’s cumulative liability for gross unrecognized tax benefits was $9,978.

The Company continues to recognize interest and penalties associated with uncertain tax positions as a component of taxes on income in its Consolidated Statement of Income. The Company had accrued $1,850 for cumulative interest and $911 for cumulative penalties at December 31, 2009. The Company has recognized ($104) for interest and $118 for penalties on its Consolidated Statement of Income for the three-month period ended March 31, 2010 and at that date, the Company had accrued $1,649 for cumulative interest and $992 for cumulative penalties.

During the quarter ended March 31, 2010, the Company derecognized several uncertain tax positions due to expiration of the applicable statutes of limitations for certain tax years. As a result, the Company recognized a $923 decrease in its cumulative liability for gross unrecognized tax benefits. The Company estimates that during the year ended December 31, 2010 it will reduce its cumulative liability for gross unrecognized tax benefits by approximately $1,800 to $1,900 due to the expiration of the statute of limitations with regard to certain tax positions. This estimated reduction in the cumulative liability for unrecognized tax benefits does not consider any increase in liability for unrecognized tax benefits with regard to existing tax positions or any increase in cumulative liability for unrecognized tax benefits with regard to new tax positions for the year ended December 31, 2010.

The Company and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various state and foreign tax jurisdictions. Tax years that remain subject to examination by major tax jurisdictions include the Netherlands and United Kingdom from 2004, Italy, Brazil, China and Spain from 2005, United States from 2006, France from 2008, and various domestic state tax jurisdictions from 1993.

Note 5 – Fair Value Measurements

The FASB’s guidance regarding fair value measurements establishes a common definition for fair value to be applied to guidance requiring use of fair value, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements. The guidance does not require any new fair value measurements, but rather applies to all other accounting guidance that requires or permits fair value measurements.

The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

 

   

Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

 

   

Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

 

   

Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

The Company values its interest rate swaps, company-owned life insurance policies and various deferred compensation assets and liabilities at fair value. The Company’s assets and liabilities subject to fair value measurement are as follows (in thousands):

 

7


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

     Fair Value
as of
March 31, 2010
   Fair Value Measurements at March 31,  2010
Using Fair Value Hierarchy
        Level 1    Level 2    Level 3

Assets

           

Company-owned life insurance

   $ 1,934    $ —      $ 1,934    $ —  

Company-owned life insurance - Deferred compensation assets

     587      —        587      —  

Other deferred compensation assets

           

Large capitalization registered investment companies

     64      64      —        —  

Mid capitalization registered investment companies

     4      4      —        —  

Small capitalization registered investment companies

     7      7      —        —  

International developed and emerging markets registered investment companies

     37      37      —        —  

Fixed income registered investment companies

     10      10      —        —  
                           

Total

   $ 2,643    $ 122    $ 2,521    $ —  
                           
     Fair Value
as of
March 31, 2010
   Fair Value Measurements at March 31, 2010
Using Fair Value Hierarchy
        Level 1    Level 2    Level 3

Liabilities

           

Deferred compensation liabilities

           

Large capitalization registered investment companies

   $ 586    $ 586    $ —      $ —  

Mid capitalization registered investment companies

     77      77      —        —  

Small capitalization registered investment companies

     122      122      —        —  

International developed and emerging markets registered investment companies

     195      195      —        —  

Fixed income registered investment companies

     51      51      —        —  

Fixed general account

     175      —        175      —  

Interest rate derivatives

     1,956      —        1,956      —  
                           

Total

   $ 3,162    $ 1,031    $ 2,131    $ —  
                           
     Fair Value
as of
December 31, 2009
   Fair Value Measurements at December 31,  2009
Using Fair Value Hierarchy
        Level 1    Level 2    Level 3

Assets

           

Company-owned life insurance

   $ 1,869    $ —      $ 1,869    $ —  

Company-owned life insurance - Deferred compensation assets

     622      —        622      —  

Other deferred compensation assets

           

Large capitalization registered investment companies

     64      64      —        —  

Mid capitalization registered investment companies

     4      4      —        —  

Small capitalization registered investment companies

     7      7      —        —  

International developed and emerging markets registered investment companies

     39      39      —        —  

Fixed income registered investment companies

     11      11      —        —  
                           

Total

   $ 2,616    $ 125    $ 2,491    $ —  
                           

 

8


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

     Fair Value
as of
December 31, 2009
   Fair Value Measurements at December 31,  2009
Using Fair Value Hierarchy
        Level 1    Level 2    Level 3

Liabilities

           

Deferred compensation liabilities

           

Large capitalization registered investment companies

   $ 557    $ 557    $ —      $ —  

Mid capitalization registered investment companies

     98      98      —        —  

Small capitalization registered investment companies

     108      108      —        —  

International developed and emerging markets registered investment companies

     205      205      —        —  

Fixed income registered investment companies

     64      64      —        —  

Fixed general account

     184      —        184      —  

Interest rate derivatives

     2,160      —        2,160      —  
                           

Total

   $ 3,376    $ 1,032    $ 2,344    $ —  
                           

The fair values of Company-owned life insurance (“COLI”) and COLI deferred compensation assets are based on quotes for like instruments with similar credit ratings and terms. The fair values of Other deferred compensation assets and liabilities are based on quoted prices in active markets, with the exception of the fixed general account, which is based on quotes for like instruments with similar credit ratings and terms. The fair values of interest rate derivatives are based on quoted market prices from various banks for similar instruments. Upon review of the underlying assets upon which the deferred compensation liabilities are based, the Company reclassified the fixed general account from Level 1 to Level 2 as of December 31, 2009.

Note 6 – Hedging Activities

The Company is exposed to the impact of changes in interest rates, foreign currency fluctuations, changes in commodity prices and credit risk. The Company does not use derivative instruments to mitigate the risks associated with foreign currency fluctuations, changes in commodity prices or credit risk. Quaker uses interest rate swaps to mitigate the impact of changes in interest rates. The swaps convert a portion of the Company’s variable interest rate debt to fixed interest rate debt and are designated as cash flow hedges and reported on the balance sheet at fair value. The effective portions of the hedges are reported in Other Comprehensive Income (“OCI”) until reclassified to earnings during the same period the hedged item affects earnings. The Company has no derivatives designated as fair value hedges and only has derivatives designated as hedging instruments under the FASB’s guidance. The notional amount of the Company’s interest rate swaps was $40,000 as of March 31, 2010 and December 31, 2009.

Information about the Company’s interest rate derivatives is as follows (in thousands of dollars):

 

          Fair Value
    

Balance Sheet Location

   March 31,
2010
   December 31,
2009

Derivatives designated as cash flow hedges:

        

Interest rate swaps

   Other current liabilities    $ 753    $ 1,006

Interest rate swaps

   Other non-current liabilities      1,203      1,154
                
      $ 1,956    $ 2,160
                

Cash Flow Hedges

Interest Rate Swaps

 

          Three Months Ended
March 31,
 
          2010     2009  

Amount of Gain (Loss) Recognized in Accumulated OCI on Derivative (Effective Portion)

      $ 105      $ 68   
                   

Amount and Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

   Interest Expense    $ (454   $ (329
                   

Amount and Location of Gain (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing)

   Other Income    $ —        $ —     
                   

 

9


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

Note 7 – Stock-Based Compensation

The Company recognized approximately $727 of share-based compensation expense for the three months ended March 31, 2010. The compensation expense was comprised of $95 related to stock options, $292 related to nonvested stock awards, $11 related to the Company’s Employee Stock Purchase Plan, $297 related to the Company’s non elective 401(k) matching contribution in stock, and $32 related to the Company’s Director Stock Ownership Plan. The Company also recognized $321 of excess tax benefits related to stock option exercises in the first quarter of 2010.

Based on historical experience, the Company has assumed a forfeiture rate of 13% on the nonvested stock. The Company will record additional expense if the actual forfeiture rate is lower than estimated, and will record a recovery of prior expense if the actual forfeiture is higher than estimated.

The Company has a long-term incentive program (“LTIP”) for key employees which provides for the granting of options to purchase stock at prices not less than market value on the date of the grant. Most options become exercisable between one and three years after the date of the grant for a period of time determined by the Company not to exceed seven years from the date of grant for options issued in 1999 or later. Common stock awards issued under the LTIP program are subject only to time vesting over a three to five-year period. In addition, as part of the Company’s Global Annual Incentive Plan (“GAIP”), nonvested shares may be issued to key employees, which generally vest over a two to five-year period.

Stock option activity under all plans is as follows:

 

     Number of
Shares
    Weighted Average
Exercise Price per
Share
   Weighted Average
Remaining Contractual
Term (years)

Balance at December 31, 2009

   526,508      $ 16.66   

Options granted

   110,939        18.82   

Options exercised

   (5,871     13.25   

Options expired

   (4,800     20.18   
           

Balance at March 31, 2010

   626,776      $ 17.05    4.0
           

Exercisable at March 31, 2010

   387,795      $ 19.32    2.6
           

As of March 31, 2010, the total intrinsic value of options outstanding was approximately $6,164, and the total intrinsic value of exercisable options was $2,933. Intrinsic value is calculated as the difference between the current market price of the underlying security and the strike price of a related option.

A summary of the Company’s outstanding stock options at March 31, 2010 is as follows:

 

Range of

Exercise Prices

   Number
Outstanding
at 3/31/2010
   Weighted
Average
Contractual
Life
   Weighted
Average
Exercise
Price
   Number
Exercisable
at
3/31/2010
   Weighted
Average
Exercise
Price

$5.33 - $7.98

   162,919    5.9    $ 6.93    52,262    $ 6.93

$7.99 - $18.62

   —      —        —      —        —  

$18.63 - $21.28

   313,344    4.0      19.33    185,020      19.63

$21.29 - $23.94

   131,513    2.1      22.82    131,513      22.82

$23.95 - $26.60

   19,000    1.0      26.05    19,000      26.05
                  
   626,776    4.0      17.05    387,795      19.32
                  

As of March 31, 2010, unrecognized compensation expense related to options granted during 2008 was $60, for options granted during 2009 was $216 and for options granted in 2010 was $647.

During the first quarter of 2010, the Company granted 110,939 stock options under the Company’s LTIP plan that are subject only to time vesting over a three-year period. The options were valued using the Black-Scholes model with the following assumptions: dividend yield of 5.1%, expected volatility of 53.72%, a risk free interest rate of 2.85%, an expected term of six years, and a forfeiture rate of 3% over the remaining life of the options. Approximately $38 of expense was recorded on these options during the first quarter of 2010. The fair value of these awards is amortized on a straight-line basis over the vesting period of the awards.

 

10


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

Under the Company’s LTIP plan, 158,207 shares of nonvested stock were outstanding at December 31, 2009. In the first quarter of 2010, 41,204 shares of nonvested stock were granted at a weighted average grant date fair value of $18.82. As of March 31, 2010, no shares were forfeited, 16,600 shares vested and 182,811 were outstanding. The fair value of the nonvested stock is based on the trading price of the Company’s common stock on the date of grant. The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards. As of March 31, 2010, unrecognized compensation expense related to these awards was $1,341, to be recognized over a weighted average remaining period of 2.22 years.

Under the Company’s GAIP plan, 69,675 shares were outstanding at December 31, 2009. Through March 31, 2010, no shares were granted, 4,375 shares vested, 750 shares were forfeited and 64,550 shares were outstanding. As of March 31, 2010, unrecognized compensation expense related to these awards was $332, to be recognized over a weighted average remaining period of 2.0 years.

Employee Stock Purchase Plan

In 2000, the Board adopted an Employee Stock Purchase Plan (“ESPP”) whereby employees may purchase Company stock through a payroll deduction plan. Purchases are made from the plan and credited to each participant’s account at the end of each month, the “Investment Date.” The purchase price of the stock is 85% of the fair market value on the Investment Date. The plan is compensatory and the 15% discount is expensed on the Investment Date. All employees, including officers, are eligible to participate in this plan. A participant may withdraw all uninvested payment balances credited to a participant’s account at any time by giving written notice to the Committee. An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.

2003 Director Stock Ownership Plan

In March 2003, the Company’s Board of Directors approved a stock ownership plan for each member of the Company’s Board to encourage the Directors to increase their investment in the Company. The Plan was effective on the date it was approved and remains in effect for a term of ten years or until it is earlier terminated by the Board. The maximum number of shares of Common Stock which may be issued under the Plan is 75,000, subject to certain conditions that the Compensation/Management Development Committee (the “Committee”) may elect to adjust the number of shares. As of December 31, 2009, the Committee has not made any elections to adjust the shares under this plan. Each Director is eligible to receive an annual retainer for services rendered as a member of the Board of Directors. Currently, each Director who owns less than 7,500 shares of Company Common Stock is required to receive 75% of the annual retainer in Common Stock and 25% of the annual retainer in cash. Each Director who owns 7,500 or more shares of Company Common Stock receives 25% of the annual retainer in Common Stock and 75% of the annual retainer in cash with the option to receive Common Stock in lieu of the cash portion of the retainer. Currently, the annual retainer is $32. The number of shares issued in payment of the fees is calculated based on an amount equal to the average of the closing prices per share of Common Stock as reported on the composite tape of the New York Stock Exchange for the two trading days immediately preceding the retainer payment date. The retainer payment date is June 1. The Company recorded $32 for each of the three months ended March 31, 2010 and 2009.

Note 8 – Earnings Per Share

The Company applies FASB’s guidance regarding the calculation of earnings per share using the two-class method. The Company includes nonvested stock awards with rights to non-forfeitable dividends as part of its basic weighted average share calculation.

The following table summarizes earnings per share (EPS) calculations:

 

    Three Months Ended March 31,  
    2010     2009  

Basic Earnings per Common Share

   

Net income attributable to Quaker Chemical Corporation

  $ 9,419      $ 2   

Less: income allocated to participating securities

    (202 )     (21
               

Net income (loss) available to common shareholders

  $ 9,217      $ (19

Basic weighted average common shares outstanding

    10,879,225        10,745,286   

Basic earnings per common share

  $ 0.85      $ 0.00   

Diluted Earnings per Common Share

   

Net income attributable to Quaker Chemical Corporation

  $ 9,419      $ 2   

Less: income allocated to participating securities

    (201     (21
               

Net income (loss) available to common shareholders

  $ 9,218      $ (19

Basic weighted average common shares outstanding

    10,879,225        10,745,286   

Effect of dilutive securities, common shares outstanding

    118,513        —     
               

Diluted weighted average common shares outstanding

    10,997,738        10,745,286   

Diluted earnings per common share

  $ 0.84      $ 0.00   

 

11


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

The following number of stock options are not included in the diluted earnings per share since in each case the exercise price is greater than the market price and the effect would have been anti-dilutive: 142,413 and 529,608 for the three months ended March 31, 2010 and 2009, respectively.

Note 9 – Business Segments

The Company organizes its segments by type of product sold. The Company’s reportable segments are as follows:

(1) Metalworking process chemicals – industrial process fluids for various heavy industrial and manufacturing applications.

(2) Coatings – temporary and permanent coatings for metal and concrete products and chemical milling maskants.

(3) Other chemical products – other various chemical products.

Segment data includes direct segment costs as well as general operating costs.

The table below presents information about the reported segments:

 

     Three Months Ended
March 31,
 
     2010     2009  

Metalworking Process Chemicals

    

Net Sales

   $ 121,205      $ 90,799   

Operating Income

     25,519        9,639   

Coatings

    

Net Sales

     6,764        7,300   

Operating Income

     1,408        1,526   

Other Chemical Products

    

Net Sales

     351        408   

Operating Income

     (57     (64
                

Total

    

Net Sales

     128,320        98,507   

Operating Income

     26,870        11,101   

Restructuring and related charges

     —          (2,289

Non-operating expenses

     (12,945     (8,827

Amortization

     (254     (257

Interest expense

     (1,311     (1,242

Interest income

     184        153   

Other income, net

     763        1,454   
                

Consolidated income before taxes and equity in net loss of associated companies

   $ 13,307      $ 93   
                

Operating income comprises revenue less related costs and expenses. Non-operating items primarily consist of general corporate expenses identified as not being a cost of operation, interest expense, interest income, and license fees from non-consolidated affiliates.

 

12


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

Note 10 – Equity, Noncontrolling Interest and Comprehensive Income (Loss)

The following table presents the changes in equity, noncontrolling interest and comprehensive income (loss) for the three months ended March 31, 2010 and 2009:

 

     Common
stock
   Capital in
excess  of
par value
   Retained
earnings
    Accumulated
other
comprehensive
loss
    Noncontrolling
Interest
    Comprehensive
Income (Loss)
    Total  

Balance at December 31, 2009

   $ 11,086    $ 27,527    $ 123,140      $ (10,439   $ 4,981        $ 156,295   

Net income

     —        —        9,419          618      $ 10,037     

Currency translation adjustments

     —        —        —          (3,998     151        (3,847  

Defined benefit retirement plans

     —        —        —          269        —          269     

Current period changes in fair value of derivatives

     —        —        —          105        —          105     

Unrealized gain on available-for-sale securities

     —        —        —          5        —          5     
                      

Comprehensive income

                 6,569        6,569   
                      

Comprehensive loss attributable to noncontrolling interest

                 (769  
                      

Comprehensive income attributable to Quaker Chemical Corporation

               $ 5,800     
                      

Dividends ($0.23 per share)

     —        —        (2,565     —          —            (2,565

Share issuance and equity-based compensation plans

     66      796      —          —          —            862   

Excess tax benefit from stock option exercises

     —        1,954      —          —          —            1,954   
                                                

Balance at March 31, 2010

   $ 11,152    $ 30,277    $ 129,994      $ (14,058   $ 5,750        $ 163,115   
                                                

Balance at December 31, 2008

   $ 10,833    $ 25,238    $ 117,089      $ (27,237   $ 3,952        $ 129,875   

Net income

     —        —        2         200      $ 202     

Currency translation adjustments

     —        —        —          (2,599     (64     (2,663  

Defined benefit retirement plans

     —        —        —          289        —          289     

Current period changes in fair value of derivatives

     —        —        —          68        —          68     

Unrealized loss on available-for-sale securities

     —        —        —          (11     —          (11  
                      

Comprehensive loss

                 (2,115     (2,115

Comprehensive loss attributable to noncontrolling interest

                 (136  
                      

Comprehensive loss attributable to Quaker Chemical Corporation

               $ (2,251  
                      

Share issuance and equity-based compensation plans

     164      257      —          —          —            421   
                                                

Balance at March 31, 2009

   $ 10,997    $ 25,495    $ 117,091      $ (29,490   $ 4,088        $ 128,181   
                                                

During the first quarter of 2010, the Company recorded $1,954 of excess tax benefits in capital in excess of par value on its Condensed Consolidated Balance Sheet, related to stock option exercises, which occurred over prior years. Previously, the Company’s actual taxable income in affected jurisdictions was not sufficient to recognize these benefits, while the Company’s full-year 2010 projection of taxable income is expected to be sufficient to recognize these benefits. As a result, the Company recognized $321 of these benefits as a cash inflow from financing activities in its Condensed Consolidated Statement of Cash Flows which represents the Company’s estimate of cash savings through March 31, 2010.

Note 11 – Goodwill and Other Intangible Assets

The changes in carrying amount of goodwill for the three months ended March 31, 2010 are as follows. The Company has recorded no impairment charges in the past:

 

     Metalworking
Process
Chemicals
    Coatings    Total  

Balance as of December 31, 2009

   $ 38,434      $ 8,081    $ 46,515   

Currency translation adjustments

     (1,006     —        (1,006
                       

Balance as of March 31, 2010

   $ 37,428      $ 8,081    $ 45,509   
                       

 

13


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of March 31, 2010 and December 31, 2009 are as follows:

 

     Gross Carrying
Amount
   Accumulated
Amortization
     2010    2009    2010    2009

Amortized intangible assets

           

Customer lists and rights to sell

   $ 8,255    $ 8,373    $ 4,497    $ 4,428

Trademarks and patents

     1,788      1,788      1,788      1,788

Formulations and product technology

     3,278      3,278      2,514      2,450

Other

     3,373      3,409      3,223      3,203
                           

Total

   $ 16,694    $ 16,848    $ 12,022    $ 11,869
                           

The Company recorded $254 and $257 of amortization expense in the first three months of 2010 and 2009, respectively. Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:

 

For the year ended December 31, 2010

   $ 886

For the year ended December 31, 2011

   $ 818

For the year ended December 31, 2012

   $ 721

For the year ended December 31, 2013

   $ 540

For the year ended December 31, 2014

   $ 305

For the year ended December 31, 2015

   $ 305

The Company has one indefinite-lived intangible asset of $600 for trademarks recorded in connection with the Company’s 2002 acquisition of Epmar.

Note 12 – Pension and Other Postretirement Benefits

The components of net periodic benefit cost are as follows:

 

     Three Months Ended March 31,
     Pension Benefits     Other
Postretirement
Benefits
     2010     2009     2010    2009

Service cost

   $ 511      $ 499      $ 4    $ 5

Interest cost and other

     1,530        1,602        99      143

Expected return on plan assets

     (1,384     (1,183     —        —  

Other amortization, net

     402        427        13      25
                             

Net periodic benefit cost

   $ 1,059      $ 1,345      $ 116    $ 173
                             

Employer Contributions:

The Company previously disclosed in its financial statements for the year ended December 31, 2009, that it expected to make minimum cash contributions of $8,578 to its pension plans and $802 to its other postretirement benefit plan in 2010. As of March 31, 2010, $3,263 and $203 of contributions have been made, respectively.

Note 13 – Commitments and Contingencies

In April of 1992, the Company identified certain soil and groundwater contamination at AC Products, Inc. (“ACP”), a wholly owned subsidiary. In voluntary coordination with the Santa Ana California Regional Water Quality Board, ACP has been remediating the contamination, the principal contaminant of which is perchloroethylene (“PERC”). On or about December 18, 2004, the Orange County Water District (“OCWD”) filed a civil complaint in Superior Court, in Orange County, California against ACP and other parties potentially responsible for groundwater contamination. OCWD was seeking to recover compensatory and other damages related to the investigation and remediation of the contamination in the groundwater. Effective October 17, 2007, ACP and OCWD settled all claims related to this litigation. Pursuant to the settlement agreement with OCWD, ACP agreed to pay $2,000 in two equal payments of $1,000 (the first payment paid October 31, 2007 and the second payment paid on February 15, 2008). In addition to the $2,000 payment, ACP agreed to operate the two existing groundwater treatment systems associated with its extraction wells P-2 and P-3 so as to hydraulically contain groundwater contamination emanating from ACP’s site until such time as the concentrations of PERC are below the Federal maximum contaminant level for four consecutive quarterly sampling events. During the third quarter of 2007, the Company recognized a $3,300 charge made up of $2,000 for the settlement of the litigation, plus an increase in its reserve for its soil and water remediation program of $1,300. As of March 31, 2010, the Company believes that the range of potential-known liabilities associated with ACP contamination including the water and soil remediation program, is approximately $1,600 to $2,700, for which the Company has sufficient reserves.

 

14


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

The low and high ends of the range are based on the length of operation of the two extraction wells as determined by groundwater modeling with planned higher maintenance costs in later years if a longer treatment period is required. Costs of operation include the operation and maintenance of the extraction wells, groundwater monitoring, one-time expenses to insure P-3 is hydraulically containing the PERC plume and program management. The duration of the well operation was estimated based on historical trends in concentrations in the monitoring wells within the proximity of the applicable extraction wells. Also factored into the model was the impact of water injected into the underground aquifer from a planned recharge basin adjacent to the ACP site as well as from an injection well to be installed and operated by OCWD as part of the groundwater treatment system for contaminants which are the subject of the aforementioned litigation. Based on the modeling, it is estimated that P-2 will operate for another two years and P-3 will operate for three years to up to six years. Operation and maintenance costs were based on historical expenditures and estimated inflation. As mentioned above, a significantly higher maintenance expense was factored into the range if the system operates for the longer period. Also included in the reserve are anticipated expenditures to operate an on-site soil vapor extraction system.

The Company believes, although there can be no assurance regarding the outcome of other unrelated environmental matters, that it has made adequate accruals for costs associated with other environmental problems of which it is aware. Approximately $99 was accrued at March 31, 2010 and December 31, 2009, respectively, to provide for such anticipated future environmental assessments and remediation costs.

An inactive subsidiary of the Company that was acquired in 1978 sold certain products containing asbestos, primarily on an installed basis, and is among the defendants in numerous lawsuits alleging injury due to exposure to asbestos. The subsidiary discontinued operations in 1991 and has no remaining assets other than the proceeds from insurance settlements received. To date, the overwhelming majority of these claims have been disposed of without payment and there have been no adverse judgments against the subsidiary. Based on a continued analysis of the existing and anticipated future claims against this subsidiary, it is currently projected that the subsidiary’s total liability over the next 50 years for these claims is approximately $8,500 (excluding costs of defense). Although the Company has also been named as a defendant in certain of these cases, no claims have been actively pursued against the Company, and the Company has not contributed to the defense or settlement of any of these cases pursued against the subsidiary. These cases were handled by the subsidiary’s primary and excess insurers who had agreed in 1997 to pay all defense costs and be responsible for all damages assessed against the subsidiary arising out of existing and future asbestos claims up to the aggregate limits of the policies. A significant portion of this primary insurance coverage was provided by an insurer that is now insolvent, and the other primary insurers have asserted that the aggregate limits of their policies have been exhausted. The subsidiary challenged the applicability of these limits to the claims being brought against the subsidiary. In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in late 2005 and in the first quarter of 2007 for $15,000 and $20,000, respectively. The payments under the latest settlement and release agreement were structured to be received over a four-year period with annual installments of $5,000, the final installment which was received in the first quarter of 2010. The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. During the third quarter of 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier will pay 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims for a minimum of five years beginning July 1, 2007. At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits. The Company also believes, that if the coverage issues under the primary policies with the remaining carrier are resolved adversely to the subsidiary and all settlement proceeds were used, the subsidiary may have limited additional coverage from a state guarantee fund established following the insolvency of one of the subsidiary’s primary insurers. Nevertheless, liabilities in respect of claims may exceed the assets and coverage available to the subsidiary.

If the subsidiary’s assets and insurance coverage were to be exhausted, claimants of the subsidiary may actively pursue claims against the Company because of the parent-subsidiary relationship. Although asbestos litigation is particularly difficult to predict, especially with respect to claims that are currently not being actively pursued against the Company, the Company does not believe that such claims would have merit or that the Company would be held to have liability for any unsatisfied obligations of the subsidiary as a result of such claims. After evaluating the nature of the claims filed against the subsidiary and the small number of such claims that have resulted in any payment, the potential availability of additional insurance coverage at the subsidiary level, the additional availability of the Company’s own insurance and the Company’s strong defenses to claims that it should be held responsible for the subsidiary’s obligations because of the parent-subsidiary relationship, the Company believes it is not probable that the Company will incur any material losses. All of the asbestos cases pursued against the Company challenging the parent-subsidiary relationship are in the early stages of litigation. The Company has been successful in the past having claims naming it dismissed during initial proceedings. Since the Company may be in this early stage of litigation for some time, it is not possible to estimate additional losses or range of loss, if any.

 

15


Table of Contents

Quaker Chemical Corporation

Notes to Condensed Consolidated Financial Statements—Continued

(Dollars in thousands, except per share amounts)

(Unaudited)

 

The Company is party to other litigation which management currently believes will not have a material adverse effect on the Company’s results of operations, cash flows or financial condition.

 

16


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Executive Summary

Quaker Chemical Corporation is a leading global provider of process chemicals, chemical specialties, services, and technical expertise to a wide range of industries—including steel, automotive, mining, aerospace, tube and pipe, coatings and construction materials. Our products, technical solutions, and chemical management services enhance our customers’ processes, improve their product quality, and lower their costs.

The revenue and earnings growth in the first quarter 2010 compared to the first quarter of 2009 was primarily due to a 35% increase in product volumes across the globe as the Company continued to recover from the economic downturn. The gross margin percentage improved due to cost reduction actions, a more favorable raw material cost environment and reduced automotive chemical management services (“CMS”) revenues reported on a gross basis. The Company’s selling, general and administrative expenses increased $7.0 million primarily due to higher incentive compensation, foreign exchange rate translation and higher selling costs on increased sales.

The first quarter 2010 results included a charge of $0.03 per diluted share related to devaluation of Venezuelan Bolivar Fuerte, as well as a benefit of $0.11 per diluted share related to the expiration of applicable statutes of limitations for uncertain tax positions. The first quarter 2009 results included a restructuring charge of $0.14 per diluted share and a gain of $0.11 per diluted share related to the disposition of land in Europe.

The net result was earnings per diluted share of $0.84 for the first quarter of 2010, a considerable improvement over the breakeven results in the first quarter of 2009. The improvement was driven by high steel industry demand in China, Brazil, India and Russia while industrial demand in North America and Europe continues to gradually recover from depressed levels.

While the Company continues to add new business and will benefit from continued improvement in key steel and automotive markets, the Company anticipates somewhat lower product volumes for the second half compared to the first half of 2010. This is primarily due to credit-tightening actions in China, seasonal factors relating to timing of shipments to certain customers, the ending of inventory restocking in the Company’s end use markets and the conclusion of tax incentives for automotive purchases in several countries. The combination of somewhat lower expected demand in the second half of 2010, the lag effects as the Company recovers its margins due to higher raw material costs and our continued investment in key growth initiatives will likely dampen earnings over the remaining quarters for 2010. However, the Company expects to deliver strong earnings over the rest of 2010 as the remaining quarters are still expected to equal or exceed the earnings we achieved in 2008 before the global economic crisis began. Longer-term, the Company expects to see good growth in our key markets as we are well positioned in the fastest growing economies as well as the expected above normal growth in the more mature markets as they recover over the coming years.

CMS Discussion

In 2003, the Company began to substantially increase the size and scope of its CMS contracts. The Company currently has more than 50 CMS contracts in North America, as well as additional CMS contracts in other areas of the world. Under its traditional CMS approach, the Company effectively acts as an agent, and the revenues and costs from these sales are reported on a net sales or “pass-through” basis. Under certain of its CMS contracts, the contracts are structured differently in that the Company’s revenue received from the customer is a fee for products and services provided to the customer, which are indirectly related to the actual costs incurred. Under this alternative structure, profit is dependent on how well the Company controls product costs and achieves product conversions from other third-party suppliers to its own products. As a result, under this structure, the Company recognizes in reported revenue the gross revenue received from the CMS site customer, and in cost of goods sold the third-party product purchases, which substantially offset each other until the Company achieves significant product conversions, which may result in a decrease in reported gross margin as a percentage of sales.

In 2009, the Company had a mix of contracts with both the traditional product pass-through structure and fixed price contracts covering all services and products. As a result of the global economic downturn and its impact in the automotive sector, during 2009 and early 2010, the Company has experienced a shift in customer requirements and business circumstances where the majority of CMS contracts have reverted to the traditional product pass-through structure. However, the Company’s offerings will continue to include both approaches to CMS.

Liquidity and Capital Resources

Quaker’s cash and cash equivalents decreased to $24.8 million at March 31, 2010 from $25.1 million at December 31, 2009. The $0.3 million decrease resulted primarily from $4.8 million of cash used in operating activities, $0.3 million of cash provided by investing activities and $5.4 million of cash provided by financing activities.

 

17


Table of Contents

Net cash flows used in operating activities were $4.8 million in the first quarter of 2010 compared to $8.2 million of cash provided by operating activities in the first quarter of 2009. The Company’s improvement in net income was more than offset by increased investments in working capital. During the first quarter of 2009, the Company experienced significantly lower business activity as a result of the global economic downturn, which, in turn, greatly reduced the Company’s investment in working capital. As business volumes continued to increase throughout 2009 and in the first quarter of 2010, the Company’s need for working capital investment correspondingly increased. The Company has also been building its safety stock levels of certain inventory in response to shortages and related to the startup of our Middletown, Ohio plant expansion. The timing of incentive compensation payments in the first quarter of 2010 was the most significant factor other than changing business activity affecting the accounts payable and other accrued liabilities comparisons. In 2008, the Company’s results were below performance targets for incentive compensation, while in 2009 the Company exceeded performance targets. The Company’s first quarter 2009 disposition of land in Europe also impacted the cash flow comparisons.

Net cash flows provided by investing activities were $0.3 million in the first quarter of 2010 compared to $0.8 million of cash used in investing activities in the first quarter of 2009. The change in cash flow was driven by the first quarter 2009 final $1.0 million payment related to the 2005 acquisition of the remaining 40% interest in the Company’s Brazilian joint venture, the first quarter 2009 proceeds from disposition of land in Europe and increased 2010 cash flow from the Company’s construction fund related to the Company’s expansion of its Middletown, Ohio manufacturing facility.

In the first quarter of 2007, an inactive subsidiary of the Company reached a settlement agreement and release with one of its insurance carriers for $20.0 million. The proceeds of the settlement are restricted and can only be used to pay claims and costs of defense associated with this subsidiary’s asbestos litigation. The payments were structured to be received over a four-year period with annual installments of $5.0 million, the final installment which was received in the first quarter of 2010. During the third quarter of 2007, the same inactive subsidiary and one of its insurance carriers entered into a Claim Handling and Funding Agreement, under which the carrier will pay 27% of the defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims for a minimum of five years beginning July 1, 2007.

Net cash flows provided by financing activities were $5.4 million for the first quarter of 2010, compared to $10.2 million of cash used in financing activities for the first quarter of 2009. The majority of the change was the result of net debt borrowings in 2010 compared to net debt repayments in 2009. In the first quarter of 2010, the Company borrowed primarily to fund working capital needs from increased business activity as well as the timing of payments of incentive compensation. In the first quarter of 2009, the cash flow generated from reduced working capital investments as a result of significantly curtailed business volumes enabled the debt repayments.

The Company’s primary credit line is a $125.0 million syndicated multicurrency credit agreement with Bank of America, N.A. (administrative agent) and certain other major financial institutions, which expires in 2012. At March 31, 2010 and December 31, 2009, the Company had approximately $54.0 million and $46.4 million outstanding, respectively. The Company’s access to this credit is largely dependent on its consolidated leverage ratio covenant, which could not exceed 3.75 to 1 at March 31, 2010 and December 31, 2009. The Company’s consolidated leverage ratio was below 2.0 to 1 at both March 31, 2010 and December 31, 2009. As discussed in a Current Report on Form 8-K filed on February 20, 2009, the Company amended its credit facility to provide covenant relief related to the 2008 and 2009 restructuring programs and the CEO transition costs and temporarily increased the maximum permitted leverage ratio through March 31, 2010. Going forward, the Company’s consolidated leverage ratio cannot exceed 3.5 to 1. In February 2009, the Company also amended two Industrial Revenue Bonds totaling $15.0 million to provide for the same changes in terms as the credit facility. The Company has entered into interest rate swaps with a combined notional value of $40.0 million as of March 31, 2010, in order to fix a portion of its variable rate debt. Outstanding financial derivative instruments may expose the Company to credit loss in the event of nonperformance by the counterparties to the agreements. To manage credit risk, the Company limits its exposure to any single counterparty. However, the Company does not expect any of the counterparties to fail to meet their obligations.

At March 31, 2010, the Company’s gross liability for uncertain tax positions, including accrued interest and penalties, was $12.6 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability. However, should the entire liability be paid, the amount of the payment may be reduced by up to $6.1 million as a result of offsetting benefits in other tax jurisdictions.

The Company’s net debt-to-total-capital ratio remained strong at 24% as of March 31, 2010, compared to 31% as of March 31, 2009 and 20% as of December 31, 2009. The Company believes it is capable of supporting its operating requirements, including pension plan contributions, payments of dividends to shareholders, possible acquisitions and business opportunities, capital expenditures and possible resolution of contingencies, through internally generated funds supplemented with debt or equity as needed.

Operations

Comparison of First Quarter 2010 with First Quarter of 2009

Net sales for the first quarter were $128.3 million, up 30% from $98.5 million for the first quarter of 2009. The increase in net sales was a result of higher volumes across the globe as the Company continues to recover from the economic downturn. Product volumes increased 35%, partially offset by a 5% decline in selling price and mix. Foreign exchange rates increased revenues by approximately 7%, which was offset by lower automotive CMS revenue as a result of lower revenue reported on a gross basis. On a sequential quarterly basis product volumes increased by approximately 3%.

 

18


Table of Contents

The gross margin percentage of 36.9% represents considerable improvement over the 29.1% reported in the first quarter of 2009. This margin expansion was primarily the result of higher volumes, cost reduction actions taken, a more favorable raw material cost environment and the reduced automotive CMS revenues reported on a gross basis. The increase in gross margin percentage from the fourth quarter of 2009 was due to reduced CMS revenues reported on a gross basis, partially offset by higher costs related to the start-up of the Middletown, Ohio plant expansion, as well as increasing raw material prices and mix.

Selling, general and administrative expenses increased $7.0 million, or 26%, compared to the first quarter of 2009. Higher incentive compensation in the first quarter of 2010, compared to reductions of incentive compensation accruals in the first quarter of 2009 and foreign exchange rate increases, were the primary drivers of the increase, representing 82% of the increase. Higher commissions on improved sales and increased travel and other costs accounted for the remainder of the increase.

In response to the global economic downturn, the Company initiated restructuring programs and incurred charges of approximately $2.3 million or approximately $0.14 per diluted share, in the first quarter of 2009. The Company completed all restructuring initiatives in 2009.

The decrease in other income is primarily due to the first quarter 2009 gain related to the disposition of land in Europe. Equity in net loss of associated companies includes a charge of approximately $0.03 per diluted share, related to the first quarter 2010 devaluation of the Venezuelan Bolivar Fuerte. The increase in net income attributable to noncontrolling interests is due to stronger financial performances from those affiliates as they continue to recover from the global economic downturn.

The Company’s low first quarter 2010 effective tax rate of 24% reflects the expiration of applicable statutes of limitations for uncertain tax positions of approximately $0.11 per diluted share. The tax benefit recorded in the first quarter of 2009 reflects no tax provided for the land sale gain due to the utilization of net operating losses not previously benefited. The Company has experienced and expects to experience further volatility in its quarterly effective tax rates due to the varying timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions. The Company currently expects additional derecognition of uncertain tax positions of approximately $0.11 per diluted share to occur later in 2010. However, the Company expects a higher effective tax rate for the full year 2010, compared to the first quarter 2010 rate. During the first quarter of 2010, the Company recorded $2.0 million of excess tax benefits in capital in excess of par value on its Condensed Consolidated Balance Sheet, related to stock option exercises, which occurred over prior years. Previously, the Company’s actual taxable income in affected jurisdictions was not sufficient to recognize these benefits, while the Company’s full-year 2010 projection of taxable income is expected to be sufficient to recognize these benefits. As a result, the Company recognized $0.3 million of these benefits as a cash inflow from financing activities in its Condensed Consolidated Statement of Cash Flows which represents the Company’s estimate of cash savings through March 31, 2010. At the end of 2009, the Company had net U.S. deferred tax assets totaling $16.3 million, excluding deferred tax assets relating to additional minimum pension liabilities. The Company records valuation allowances when necessary to reduce its deferred tax assets to the amount that is more likely than not to be realized. The Company considers future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for a valuation allowance. However, in the event the Company were to determine that it would not be able to realize all or part of its net deferred tax assets in the future, an adjustment to the deferred tax assets would be a non-cash charge to income in the period such determination was made, which could have a material adverse impact on the Company’s financial statements. The global economic downturn has been negatively impacting profitability in certain taxing jurisdictions. The Company continues to closely monitor this situation as it relates to its net deferred tax assets and the assessment of valuation allowances. The Company is continuing to evaluate alternatives that could positively impact taxable income in these jurisdictions.

Segment Reviews—Comparison of the First Quarter 2010 with First Quarter 2009

Metalworking Process Chemicals

Metalworking Process Chemicals consists of industrial process fluids for various heavy industrial and manufacturing applications and represented approximately 95% of the Company’s net sales in the first quarter of 2010. Net sales were up $30.4 million, or 33%, compared to the first quarter of 2009. Foreign currency translation positively impacted net sales by approximately 8%, driven by the E.U. Euro to U.S. Dollar, and Brazilian Real to U.S. Dollar exchange rates. The average U.S. Dollar to E.U. Euro exchange rate was 1.38 in the first quarter of 2010 compared to 1.31 in the first quarter of 2009, and the average U.S. Dollar to Brazilian Real exchange rate was 0.55 in the first quarter of 2010 compared to 0.43 in the first quarter of 2009. Net sales were positively impacted by increases of 4% in North America, 25% in Europe, 48% in Asia Pacific and 63% in South America, all on a constant currency basis. The increase in this segment’s sales was primarily attributable to increased product volumes of 39% impacting all regions as the Company continues to recover from the global economic downturn. The product volume increases were partially offset by a reduction in automotive CMS revenue, which was due, in part, to the renegotiation of certain contracts now reported on a pass-through versus gross basis. Consistent with the significant volume increases, this segment’s operating income increased $15.9 million. This segment’s operating income also benefited from savings from the Company’s restructuring efforts as well as a more favorable raw material environment.

 

19


Table of Contents

Coatings

The Company’s coatings segment, which represented approximately 5% of the Company’s net sales in the first quarter of 2010, contains products that provide temporary and permanent coatings for metal and concrete products and chemical milling maskants. Net sales for this segment were down $0.5 million, or 7%, for the first quarter of 2010 compared to the first quarter of 2009, primarily due to reduced volumes of chemical milling maskants sold to the aerospace industry as well as reduced coating sales to the construction industry. This segment’s operating income was down $0.1 million, consistent with the volume decline noted above.

Other Chemical Products

Other Chemical Products, which represented less than 1% of the Company’s net sales in the first quarter of 2010, consists of sulfur removal products for industrial gas streams sold by the Company’s Q2 Technologies joint venture. Net sales were down $0.1 million as a result of the downturn in the oil and gas market. Operating income was a slight loss for the first quarter of 2010, reflective of the noted volume decline.

Factors That May Affect Our Future Results

(Cautionary Statements Under the Private Securities Litigation Reform Act of 1995)

Certain information included in this Report and other materials filed or to be filed by Quaker with the SEC (as well as information included in oral statements or other written statements made or to be made by us) contain or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on our current expectations about future events. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance and business, including:

 

   

statements relating to our business strategy;

 

   

our current and future results and plans; and

 

   

statements that include the words “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan” or similar expressions.

Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. From time to time, forward-looking statements are also included in Quaker’s other periodic reports on Forms 10-K, 10-Q and 8-K, as well as in press releases and other materials released to, or statements made to, the public.

Any or all of the forward-looking statements in this Report and in any other public statements we make may turn out to be wrong. This can occur as a result of inaccurate assumptions or as a consequence of known or unknown risks and uncertainties. Many factors discussed in this Report will be important in determining our future performance. Consequently, actual results may differ materially from those that might be anticipated from our forward-looking statements.

We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in Quaker’s subsequent reports on Forms 10-K, 10-Q and 8-K should be consulted. These forward-looking statements are subject to risks, uncertainties and assumptions about us and our operations that are subject to change based on various important factors, some of which are beyond our control. A major risk is that the Company’s demand is largely derived from the demand for its customers’ products, which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production planning shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, worldwide economic and political conditions, foreign currency fluctuations, and terrorist attacks such as those that occurred on September 11, 2001. Furthermore, the Company is subject to the same business cycles as those experienced by steel, automobile, aircraft, appliance, and durable goods manufacturers. These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. Other factors beyond those discussed could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

 

20


Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Quaker is exposed to the impact of changes of interest rates, foreign currency fluctuations, changes in commodity prices, and credit risk.

Interest Rate Risk. Quaker’s exposure to market rate risk for changes in interest rates relates primarily to its short and long-term debt. Most of Quaker’s debt is negotiated at market rates which can be either fixed or variable. Accordingly, if interest rates rise significantly, the cost of debt to Quaker will increase. This can have an adverse effect on Quaker, depending on the extent of Quaker’s borrowings. As of March 31, 2010, Quaker had $54.0 million in borrowings under its credit facilities, compared to $46.4 million at December 31, 2009, at a weighted average borrowing rate of approximately 2.54% (LIBOR plus a spread). The Company uses derivative financial instruments primarily for purposes of hedging exposures to fluctuations in interest rates. The Company does not enter into derivative contracts for trading or speculative purposes. The Company has entered into interest rate swaps in order to fix a portion of its variable rate debt. The swaps had a combined notional value of $40.0 million and a fair value of $(2.0) million and $(2.2) million at March 31, 2010 and December 31, 2009, respectively. As of the date of this Report, the Company is receiving a LIBOR rate and paying an average fixed rate of approximately 5% on its interest rate swaps. Five of the Company’s swaps with a notional value of $25.0 million mature in 2010, while the remaining three swaps with a notional value of $15.0 million mature in 2012. The counterparties to the swaps are major financial institutions. Outstanding financial derivative instruments expose the Company to credit loss in the event of nonperformance by the counterparties to the agreements. To manage credit risk, the Company limits its exposure to any single counterparty. However, the Company does not expect any of the counterparties to fail to meet their obligations. Reference is made to the information included under in Note 6 of Notes to Condensed Consolidated Financial Statements.

Foreign Exchange Risk. A significant portion of Quaker’s revenues and earnings is generated by its foreign operations. These foreign operations also hold a significant portion of Quaker’s assets and liabilities. All such operations use the local currency as their functional currency. Accordingly, Quaker’s financial results are affected by risks typical of global business such as currency fluctuations, particularly between the U.S. Dollar, the Brazilian Real, the Chinese Renminbi and the E.U. Euro. As exchange rates vary, Quaker’s results can be materially affected.

The Company generally does not use financial instruments that expose it to significant risk involving foreign currency transactions; however, the size of non-U.S. activities has a significant impact on reported operating results and the attendant net assets. During the past three most recent fiscal years, sales by non-U.S. subsidiaries accounted for approximately 58% to 62% of consolidated net annual sales.

In addition, the Company often sources inventory among its worldwide operations. This practice can give rise to foreign exchange risk resulting from the varying cost of inventory to the receiving location as well as from the revaluation of intercompany balances. The Company mitigates this risk through local sourcing efforts.

Commodity Price Risk. Many of the raw materials used by Quaker are commodity chemicals, and, therefore, Quaker’s earnings can be materially adversely affected by market changes in raw material prices. In certain cases, Quaker has entered into fixed-price purchase contracts having a term of up to one year. These contracts provide for protection to Quaker if the price for the contracted raw materials rises, however, in certain limited circumstances, Quaker will not realize the benefit if such prices decline.

Credit Risk. Quaker establishes allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. If the financial condition of Quaker’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. Downturns in the overall economic climate may also tend to exacerbate specific customer financial issues. A significant portion of Quaker’s revenues is derived from sales to customers in the U.S. steel and automotive industries, including some of our larger customers, where a number of bankruptcies occurred during recent years and companies have experienced financial difficulties. When a bankruptcy occurs, Quaker must judge the amount of proceeds, if any, that may ultimately be received through the bankruptcy or liquidation process. In addition, as part of its terms of trade, Quaker may custom manufacture products for certain large customers and/or may ship product on a consignment basis. These practices may increase the Company’s exposure should a bankruptcy occur, and may require write-down or disposal of certain inventory due to its estimated obsolescence or limited marketability. Customer returns of products or disputes may also result in similar issues related to the realizability of recorded accounts receivable or returned inventory.

 

21


Table of Contents
Item 4. Controls and Procedures.

Evaluation of disclosure controls and procedures. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is accumulated and communicated to the issuer’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on their evaluation of such controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)), are effective to provide reasonable assurance that information required to be disclosed by the Company in the reports it files under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission.

Changes in internal controls. At the end of 2009, subsidiaries representing approximately 80% of consolidated revenue were operational on the Company’s global ERP system. The Company is currently in the process of adding additional locations to its global ERP system in 2010. The Company is taking the necessary steps to monitor and maintain its internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)) during this period of change.

 

22


Table of Contents

PART II. OTHER INFORMATION

Items 1, 1A, 2, 3, 4 and 5 of Part II are inapplicable and have been omitted.

 

Item 6. Exhibits

(a) Exhibits

 

10.1        Amended Expatriate Agreement by and between Jan F. Nieman and Quaker Chemical (China) Ltd., Quaker Chemical Limited (Hong Kong) and Quaker Chemical B.V., all subsidiaries of Registrant, dated April 6, 2010, Effective March 1, 2010.*
10.2        Employment Agreement by and between Registrant and Joseph Berquist dated April 1, 2010.*
10.3        Change in Control Agreement by and between Registrant and Joseph Berquist dated April 1, 2010.*
31.1        Certification of Chief Executive Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
31.2        Certification of Chief Financial Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
32.1        Certification of Michael F. Barry Pursuant to 18 U.S. C. Section 1350
32.2        Certification of Mark A. Featherstone Pursuant to 18 U.S. C. Section 1350

 

* This exhibit is a management contract or compensation plan or arrangement required to be filed as an exhibit.

*********

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

QUAKER CHEMICAL CORPORATION

                         (Registrant)

        /S/    MARK A. FEATHERSTONE        
Date: April 27, 2010    

Mark A. Featherstone, officer duly authorized to sign this

report, Vice President, Chief Financial Officer and Treasurer

 

23